** Medical diagnostics co Lantheus Holdings' shares up ~7.1% at $85.05
** LNTH announces a program to repurchase up to $250 mln of its common shares during the next 12 months
** The timing, number and dollar amount of repurchase transaction will be at management's discretion
** "We intend to commence repurchases in the fourth quarter of this year and opportunistically return capital to shareholders over the next twelve months," said CEO Brian Markison
** 11 of 12 brokerages rate the stock "buy" or higher, 1 "hold"; their median PT is $135 — data compiled by LSEG
** Including session's moves, stock up ~37% YTD
(Reporting by Prakhar Srivastava in Bengaluru)
((Prakhar.srivastava2@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。